-CR/ER Tablets: Procedure of insomnia characterised by complications with sleep onset and/or slumber routine maintenance (as measured by wake time just after rest onset)Exclusivity is the only real marketing legal rights granted from the FDA to your manufacturer on the approval of the drug and may operate concurrently having a patent. Exclusivity d